BLOCKADE OF ACQUISITION OF DRUG-CONDITIONED PLACE AVERSION BY 5HT3 ANTAGONISTS

被引:35
作者
ACQUAS, E [1 ]
CARBONI, E [1 ]
GARAU, L [1 ]
DICHIARA, G [1 ]
机构
[1] UNIV CAGLIARI, INST EXPTL PHARMACOL & TOXICOL, VIALE A DIAZ 182, I-09126 CAGLIARI, ITALY
关键词
5-HT; 5HT[!sub]3[!/sub] antagonist; Naloxone; Phencyclidine; Picrotoxin;
D O I
10.1007/BF02243996
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The effect of two 5HT3 antagonists, ICS 205-930 and MDL 72222, on drug-induced place aversion was studied in a two-compartment apparatus with a procedure including a pre-test for spontaneous preference. Naloxone (0.8 mg/kg SC), phencyclidine (2.5 mg/kg SC) and picrotoxin (2.0 mg/kg IP) paired with the preferred compartment elicited a significant place aversion. ICS 205-930 and MDL 72222 failed to modify spontaneous place preference when paired with both compartments. ICS 205-930 (30 μg/kg SC) paired with the preferred and, in other experiments, with the non-preferred compartment, also failed to modify spontaneous preference. ICS 205-930 (7.5, 15 and 30 μg/kg SC), paired with both compartments, dose-dependently reduced the place aversion induced by naloxone (0.8 mg/kg SC), phencyclidine (2.5 mg/kg SC) and picrotoxin (2.0 mg/kg IP). MDL 72222 (30 μg/kg SC) paired with both compartments had a similar effect. The result indicate that 5HT, via 5HT3 receptors, plays a role in the aversive properties of drug stimuli. © 1990 Springer-Verlag.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 14 条
  • [1] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [2] 5HT3 RECEPTOR ANTAGONISTS BLOCK MORPHINE-INDUCED AND NICOTINE-INDUCED BUT NOT AMPHETAMINE-INDUCED REWARD
    CARBONI, E
    ACQUAS, E
    LEONE, P
    DICHIARA, G
    [J]. PSYCHOPHARMACOLOGY, 1989, 97 (02) : 175 - 178
  • [3] DIFFERENTIAL INHIBITORY EFFECTS OF A 5-HT3 ANTAGONIST ON DRUG-INDUCED STIMULATION OF DOPAMINE RELEASE
    CARBONI, E
    ACQUAS, E
    FRAU, R
    DICHIARA, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 164 (03) : 515 - 519
  • [4] ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION
    CHOPIN, P
    BRILEY, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) : 383 - 388
  • [5] NEUROANATOMICAL SITES OF ACTION OF 5-HT3 RECEPTOR AGONIST AND ANTAGONISTS FOR ALTERATION OF AVERSIVE BEHAVIOR IN THE MOUSE
    COSTALL, B
    KELLY, ME
    NAYLOR, RJ
    ONAIVI, ES
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 325 - 332
  • [6] A 5-HT RECEPTOR IN THE CENTRAL NERVOUS-SYSTEM, POSITIVELY COUPLED WITH ADENYLATE-CYCLASE, IS ANTAGONIZED BY ICS-205-930
    DUMUIS, A
    BOUHELAL, R
    SEBBEN, M
    BOCKAERT, J
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 146 (01) : 187 - 188
  • [8] IWAMOTO E T, 1986, Alcohol and Drug Research, V6, P265
  • [9] JONES B J, 1987, British Journal of Pharmacology, V90, p88P
  • [10] THE POTENTIAL ANXIOLYTIC ACTIVITY OF GR38032F, A 5-HT3-RECEPTOR ANTAGONIST
    JONES, BJ
    COSTALL, B
    DOMENEY, AM
    KELLY, ME
    NAYLOR, RJ
    OAKLEY, NR
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) : 985 - 993